(Q42614939)

3 November 2017

title

A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam (English)

1 reference

3 November 2017

1 reference

1 reference

Sisson TL

1

1 reference

3 November 2017

Jungbluth GL

series ordinal

2

1 reference

3 November 2017

Hopkins NK

series ordinal

3

1 reference

3 November 2017

publication date

1 December 1999

1 reference

The Journal of Clinical Pharmacology

3 November 2017

published in

1 reference

3 November 2017

volume

39

1 reference

3 November 2017

issue

12

1 reference

3 November 2017

page(s)

1277-1282

1 reference

Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

The mechanism of action of DuP 721, a new antibacterial agent: effects on macromolecular synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

Clinical pharmacokinetics of aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

Clinical pharmacokinetics of aztreonam. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922011962

10.1177/00912709922011962

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference